Advertisement

Topics

Pfizer gets FDA nod for blood cancer treatment Besponsa

02:23 EDT 18 Aug 2017 | Pharmaceutical Business Review

Pfizer has secured approval from the US Food and Drug Administration (FDA) for its Besponsa (inotuzumab ozogamicin) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Original Article: Pfizer gets FDA nod for blood cancer treatment Besponsa

NEXT ARTICLE

More From BioPortfolio on "Pfizer gets FDA nod for blood cancer treatment Besponsa"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...